Title | Author(s) | Issue date | ???itemlist.??? |
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study | Aravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study | Aravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials | Kosmidis, P. A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. | 24-Nov-2015 | - |
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group | Kosmidis, P. A.; Tsavaris, N.; Skarlos, D.; Theocharis, D.; Samantas, E.; Pavlidis, N.; Briassoulis, E.; Fountzilas, G. | 24-Nov-2015 | - |
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study | Kosmidis, P. A.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanasiadis, A.; Andreopoulou, E.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG) | Kosmidis, P. A.; Fountzilas, G.; Eleftheraki, A. G.; Kalofonos, H. P.; Pentheroudakis, G.; Skarlos, D.; Dimopoulos, M. A.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Boukovinas, J.; Lambaki, S.; Katirtzoglou, N.; Bakogiannis, C.; Syrigos, K. N. | 24-Nov-2015 | - |
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study | Fostira, F.; Tsitlaidou, M.; Papadimitriou, C.; Pertesi, M.; Timotheadou, E.; Stavropoulou, A. V.; Glentis, S.; Bournakis, E.; Bobos, M.; Pectasides, D.; Papakostas, P.; Pentheroudakis, G.; Gogas, H.; Skarlos, P.; Samantas, E.; Bafaloukos, D.; Kosmidis, P. A.; Koutras, A.; Yannoukakos, D.; Konstantopoulou, I.; Fountzilas, G. | 24-Nov-2015 | - |
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2 | Kosmidis, P. A.; Syrigos, K.; Kalofonos, H. P.; Dimopoulos, M. A.; Skarlos, D.; Pavlidis, N.; Boukovinas, I.; Bafaloukos, D.; Pectasides, D.; Bacoyiannis, C.; Fountzilas, G. | 24-Nov-2015 | - |